StockData
Unicycive Therapeutics, Inc. logo

Unicycive Therapeutics, Inc. (UNCY) stock

UNCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$3.70+0.00 (0.00%)

Close on Nov 17, 2026Market cap $103.06MP/E –Yield –

Unicycive Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Unicycive Therapeutics's enterprise value was $43.87M on Nov 11, 2026, against $92.21M a year earlier. Over the last 5 years it ranged from -$32.49M to $131.67M, with a median of $19.35M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$43.87M-43.5%
2025Dec 31, 2025$77.61M+71.1%
2024Dec 31, 2024$45.37M+187.0%
2023Dec 29, 2023$15.81M+1290.0%
2022Dec 30, 2022$1.14M-91.1%
2021Dec 31, 2021$12.83M–

More Unicycive Therapeutics figures

See a number that looks wrong?